Loading clinical trials...
Loading clinical trials...
Breast cancer is the most common malignant tumor in women. Surgical treatment is the most important treatment for early breast cancer. Breast cancer resection is considered to be a destructive operati...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Peking University People's Hospital
NCT04886791 · Hysterectomy, Natural Orifice Transluminal Endoscopic Surgery, and more
NCT06870903 · Endometrial Cancer, Lymphadenectomy, and more
NCT06629012 · Breast Reconstruction, Breast Cancer Patients, and more
NCT07579117 · Endoscopic Video-assisted Nipple-sparing Mastectomy, Breast Surgery, and more
NCT07337980 · Interstitialoma, Endoscopic Surgery
Peking University People's Hospital
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions